Ipca Laboratories Ltd
₹1533.90
(2.86%)
Thu, 12 Mar 2026, 10:49 pm
Ipca Laboratories Shareholding
| Shareholders | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 | DEC 2024 |
|---|---|---|---|---|---|
| Promoters | 44.72 | 44.72 | 44.72 | 44.72 | 44.72 |
| FII | 10.63 | 10.42 | 10.67 | 10.76 | 11.07 |
| DII | 37.32 | 36.77 | 36.20 | 36.06 | 35.68 |
| Public | 7.33 | 8.08 | 8.40 | 8.46 | 8.53 |
| Government | 0 | 0 | 0 | 0 | 0 |
Ipca Laboratories Ltd Shareholding Pattern
The Ipca Laboratories Ltd shareholding pattern provides detailed insights into how ownership of the company is distributed among promoters, FIIs, DIIs, public investors, and government entities. Tracking the Ipca Laboratories Ltd shareholding structure helps investors understand institutional confidence, promoter commitment, and overall market sentiment.
Ipca Laboratories Ltd (NSE: IPCALAB, BSE: 524494) operates in the Health technology sector and Pharmaceuticals: major industry. Monitoring the Ipca Laboratories Ltd shareholding pattern regularly allows investors to analyze ownership trends and make informed investment decisions.
Ipca Laboratories Ltd Shareholding Pattern (Latest)
The latest Ipca Laboratories Ltd shareholding for Dec 2025 is:
- Promoters: 44.72%
- FII: 10.63%
- DII: 37.32%
- Public: 7.33%
- Government: 0%
Promoter holding in Ipca Laboratories Ltd remains stable, reflecting consistent long-term commitment.
Ipca Laboratories Ltd Promoter Holding Trend
Promoter shareholding plays a crucial role in evaluating management confidence in Ipca Laboratories Ltd.
- Dec 2025: 44.72%
- Sept 2025: 44.72%
- Jun 2025: 44.72%
- Mar 2025: 44.72%
- Dec 2024: 44.72%
Promoter stake remains largely stable, showing consistent ownership structure.
Ipca Laboratories Ltd FII Shareholding Trend
Foreign Institutional Investors (FIIs) reflect global investor sentiment toward Ipca Laboratories Ltd.
- Dec 2025: 10.63%
- Sept 2025: 10.42%
- Jun 2025: 10.67%
- Mar 2025: 10.76%
- Dec 2024: 11.07%
FII holding in Ipca Laboratories Ltd has increased recently, indicating rising foreign investor interest.
Ipca Laboratories Ltd DII Shareholding Trend
Domestic Institutional Investors (DIIs) include mutual funds, banks, and insurance companies.
- Dec 2025: 37.32%
- Sept 2025: 36.77%
- Jun 2025: 36.20%
- Mar 2025: 36.06%
- Dec 2024: 35.68%
DII stake in Ipca Laboratories Ltd has increased over time, indicating growing domestic institutional confidence.
Ipca Laboratories Ltd Public Shareholding Trend
Public shareholding represents retail and non-institutional investors.
- Dec 2025: 7.33%
- Sept 2025: 8.08%
- Jun 2025: 8.40%
- Mar 2025: 8.46%
- Dec 2024: 8.53%
Public holding remains stable with consistent retail participation.
Ipca Laboratories Ltd Government Holding
Government holding in Ipca Laboratories Ltd currently stands at 0%.
Ipca Laboratories Ltd operates without significant government ownership.
Ipca Laboratories Ltd Shareholding Analysis Summary
The Ipca Laboratories Ltd shareholding pattern highlights the ownership structure and investor confidence in the company. Stable promoter holdings combined with institutional participation often indicate strong fundamentals and long-term growth potential.
Ipca Laboratories Ltd shows strong promoter and domestic institutional confidence, which is positive for long-term investors.
Regular monitoring of the Ipca Laboratories Ltd shareholding helps investors understand market confidence, institutional activity, and potential future stock movements.
Open Your Free Demat Account Now!
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800